Riskpilot← Back to searchSign inGet full accessBonliva Care AB
ABActiveOrg 5593130510Sankt Eriksgatan 117General medical practice activities · NACE 8621Est. 202115 employees
Revenue 2024
SEK 29,6M
-52% vs 2023
EBITDA margin
-19.3%
-177% vs 2023
Equity ratio
38.0%
Financial strength
Net profit 2024
SEK -5,8M
-202% vs 2023
| Revenue | SEK 29,6M | -52% |
| EBITDA | SEK -5,7M | -177% |
| Net profit | SEK -5,8M | -202% |
| Total assets | SEK 11,6M | -38% |
| Equity | SEK 4,4M | -57% |
| Employees | 15 | — |
Legal name
Bonliva Care AB
Org number
5593130510
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
19 april 2021
Share capital
SEK 25 000
Employees
15 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva hälsoinriktade utredningar, utbildning, vård samt därtill närliggande discipliner, och därmed förenlig verksamhet
Address
Sankt Eriksgatan 117
Phone
+46851513410
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 2 960 | 30 199 | 61 175 | 29 635 |
| Staff expenses | — | — | — | — |
| EBITDA | 384 | 5 495 | 7 468 | −5 719 |
| Depreciation & amort. | −0 | −143 | −175 | −175 |
| EBIT | 384 | 5 352 | 7 293 | −5 894 |
| Net financials | — | −37 | −116 | 83 |
| Profit before tax | 384 | 5 315 | 7 177 | −5 811 |
| Tax | −79 | −1 095 | −1 503 | −0 |
| Net profit | 305 | 4 220 | 5 674 | −5 811 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1 437 | 21 763 | 18 604 | 11 601 |
| Equity | 330 | 4 550 | 10 224 | 4 413 |
| Long-term debt | 0 | 6 000 | 0 | 0 |
| Short-term debt | 1 108 | 11 213 | 8 380 | 7 188 |
| Total debt | 1 108 | 17 213 | 8 380 | 7 188 |
EBITDA margin
-19.3%
This company
15.8%
Market median
-222% vs market
20212024
Equity ratio
38.0%
This company
38.2%
Market median
+1% vs market
20212024
Return on equity
-131.7%
This company
18.4%
Market median
-816% vs market
20212024
Net profit margin
-19.6%
This company
8.1%
Market median
-342% vs market
20212024
Asset turnover
2.55×
This company
1.12×
Market median
+128% vs market
20212024
Debt / equity
1.63×
This company
0.62×
Market median
-163% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
TG Chief Executive Officer | Chief Executive Officer | 2022 |
JP Chief Executive Officer | Chief Executive Officer | 2025 |
SJ Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 69% | 69% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bonliva AB
Bonliva Care AB Board members of Bonliva Care AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ted Gustav Bergman | Chief Executive Officer | 0 companies |
| Josephine Paulin Höök | Chief Executive Officer | 0 companies |
| Sebastian Johan Lennevi | Chief Auditor | 0 companies |
| Maria Sylvia Ellinor Längqvist | Chairman | 0 companies |
| Carl Fredrik William Olsmar | Board of Directors | 0 companies |